GB1539862A - N-(acyl)-p-amino-n'-(monosubstituted)benzamide anti-ulcer agents - Google Patents

N-(acyl)-p-amino-n'-(monosubstituted)benzamide anti-ulcer agents

Info

Publication number
GB1539862A
GB1539862A GB21872/77A GB2187277A GB1539862A GB 1539862 A GB1539862 A GB 1539862A GB 21872/77 A GB21872/77 A GB 21872/77A GB 2187277 A GB2187277 A GB 2187277A GB 1539862 A GB1539862 A GB 1539862A
Authority
GB
United Kingdom
Prior art keywords
monosubstituted
benzamide
acyl
amino
ulcer agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB21872/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Inc
Original Assignee
Pfizer Corp Belgium
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Inc filed Critical Pfizer Corp Belgium
Publication of GB1539862A publication Critical patent/GB1539862A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
GB21872/77A 1976-05-26 1977-05-24 N-(acyl)-p-amino-n'-(monosubstituted)benzamide anti-ulcer agents Expired GB1539862A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/690,300 US4044147A (en) 1976-05-26 1976-05-26 N-(acyl)-p-amino-N'-(monosubstituted)-benzamide anti-ulcer agents

Publications (1)

Publication Number Publication Date
GB1539862A true GB1539862A (en) 1979-02-07

Family

ID=24771930

Family Applications (1)

Application Number Title Priority Date Filing Date
GB21872/77A Expired GB1539862A (en) 1976-05-26 1977-05-24 N-(acyl)-p-amino-n'-(monosubstituted)benzamide anti-ulcer agents

Country Status (10)

Country Link
US (1) US4044147A (enExample)
JP (1) JPS52144640A (enExample)
BE (1) BE855022A (enExample)
DE (1) DE2723051C3 (enExample)
DK (1) DK223177A (enExample)
FR (1) FR2352790A1 (enExample)
GB (1) GB1539862A (enExample)
IE (1) IE44499B1 (enExample)
LU (1) LU77403A1 (enExample)
NL (1) NL170135C (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2600513A1 (de) * 1976-01-08 1977-07-28 Hoechst Ag Acylamino(alkyl)benzolderivate und verfahren zu ihrer herstellung
US4500714A (en) * 1981-10-15 1985-02-19 Chugai Seiyaku Kabushiki Kaisha 3-Substituted-ureido-N-pyridyl benzamides
US4735956A (en) * 1985-09-13 1988-04-05 Merck & Co., Inc. Certain 1,4-dihydro-2,6-di-lower hydrocarbyl-4-heterocyclic-3,5-pyridine dicarboxylates which are useful as calcium channel blockers
US5643965A (en) * 1995-04-03 1997-07-01 Centaur Pharmaceuticals, Inc. Aminobenzamide compounds for the treatment of neurodegenerative disorders
US5658953A (en) * 1995-04-03 1997-08-19 Centaur Pharmaceuticals, Inc. Pharmaceutical compositions of acetamidobenzamide compounds for neurodegenerative disorders
US5955506A (en) * 1996-04-03 1999-09-21 Centaur Pharmaceuticals, Inc. Benzamides for neurodegenerative disorder treatment
WO2001017953A1 (en) * 1999-09-08 2001-03-15 Guilford Pharmaceuticals Inc. Non-peptidic cyclophilin binding compounds and their use
EP1360173A2 (en) 2001-01-25 2003-11-12 Guilford Pharmaceuticals Inc. Trisubstituted carbocyclic cyclophilin binding compounds and their use
WO2006137080A1 (en) * 2005-06-22 2006-12-28 Manne Satyanarayana Reddy Improved process for the preparation of ezetimibe
US20070049748A1 (en) * 2005-08-26 2007-03-01 Uppala Venkata Bhaskara R Preparation of ezetimibe

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2212268C3 (de) * 1971-03-15 1979-09-13 Sumitomo Chemical Co., Ltd., Osaka (Japan) N-Halogenacetylanilinoessigsäureester, Verfahren zu deren Herstellung und diese enthaltende herbicide Massen
JPS50157336A (enExample) * 1974-06-11 1975-12-19

Also Published As

Publication number Publication date
DK223177A (da) 1977-11-27
NL170135B (nl) 1982-05-03
DE2723051B2 (de) 1979-11-22
DE2723051A1 (de) 1977-12-01
IE44499L (en) 1977-11-26
IE44499B1 (en) 1981-12-16
LU77403A1 (enExample) 1979-01-19
FR2352790A1 (fr) 1977-12-23
JPS52144640A (en) 1977-12-02
JPS574626B2 (enExample) 1982-01-27
NL170135C (nl) 1982-10-01
NL7705565A (nl) 1977-11-29
US4044147A (en) 1977-08-23
FR2352790B1 (enExample) 1980-11-14
DE2723051C3 (de) 1980-07-31
BE855022A (fr) 1977-11-25

Similar Documents

Publication Publication Date Title
JPS5363352A (en) Transs n *2 aminooaliphaticc group*benzamide
ZA776555B (en) Benzamide derivatives
KE3162A (en) N-(azolylmethyl)-haloacetanilides and their use as herbicides
BE852104A (fr) Concentre d'agent d'expansion
ZA7731B (en) 1-(substituted amino)alkanoyl-2-(dibenzoxazepine-10-carbonyl)-hydrazines and derivatives thereof
IT8421030A1 (it) "dispositivo assortitore"
JPS52105206A (en) Novel crystal form of 22*44*22froyl*piperazinee11il**44aminoo6* 77dimethoxychinazolin hydrochloride
GB1539862A (en) N-(acyl)-p-amino-n'-(monosubstituted)benzamide anti-ulcer agents
FI833206L (fi) Bensamidoderivater
IL51513A0 (en) N-(4-benzyloxyphenyl)-n'-methyl-n'-methoxyurea
AU2854877A (en) N-aryl-n'-(cyclo)alkyl thioureas
IL51149A0 (en) N-(1,3,4-thiadiazol-2-yl) benzamides
PH12838A (en) N-(1'-allyl 2'-pyrrolidylmethyl)2,3-dimet 5-sulfamoyl benzamide,it's derivatives
ES534454A0 (es) Procedimiento para preparar n-(dicloroacetil)-glicinamidas sustituidas en posicion n y eventualmente en posicion n'
JPS5293739A (en) 3*55bis*acylamino* benzamide
PH19211A (en) N-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulphamoyl benzamide derivatives and pharmaceutical compositions
PH12847A (en) Benzamide derivatives
GB1544041A (en) N-substituted 7-amino-1,3,5-triaza-adamantane compounds their preparation and use
JPS5392783A (en) Nnsubstituted benzamide
HK12283A (en) N-(1,3,4-thiadiazol-2-4l)benzamides
IL49187A0 (en) N-(6-acyloxybenzothiazol-2-yl)-n'-phenyl(or substituted phenyl)ureas
ZA772673B (en) Benzamide derivatives
IL51137A (en) Antirhinoviral compositions containing n-(4-phenylthiazol-2-yl)-n'-phenylguanidines
ZA7723B (en) N-(1,3,4-thiadiazol-2yl)benzamides
JPS5283573A (en) Guanidine derivatives and hypotensive agents containing same

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee